Article Type
Article
Changed
Fri, 07/25/2025 - 15:36
Display Headline

Data Trends 2025: Acute Pain

Click to view more from Federal Health Care Data Trends 2025.

References
  1. Baumann L, et al. Curr Pain Headache Rep. 2023;27(9):437-444. doi:10.1007/s11916-023-01127-0
  2. Reif S, et al. Mil Med. 2018;183(9-10):e330-e337. doi:10.1093/milmed/usx200
  3. Sharp LK, e t a l . Pain. 2023;164( 4 ) : 749-757. doi:10.1097/j .pain.0000000000002759
  4. Dalton MK, et al. J Trauma Acute Care Surg. 2021;91(2S Suppl 2):S213-S220. doi:10.1097/TA.0000000000003133
  5. Mahyar L, et al. Reg Anesth Pain Med. 2024;49(2):117-121. doi:10.1136/rapm-2023-104610
  6. Gupta K, et al. Eur J Trauma Emerg Surg. 2025;51(1):103. doi:10.1007/s00068-025-02778-x
  7. Mariano ER, et al. Reg Anesth Pain Med. 2022;47(2):118-127. doi:10.1136/rapm-2021-103083
Author and Disclosure Information

Reviewed by: 

 

Terri L. Tanielian, MA, Founder, CEO, Bluebird Road Advisors, Washington, DC
Ms. Tanielian has disclosed no relevant financial relationships.

 

Scott G. Pritzlaff, MD, Associate Professor, Department of Anesthesiology and Pain Medicine, University of California, Davis, Sacramento, California
Dr. Pritzlaff has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant,
or trustee for: SPR Therapeutics; Medtronic, and Bioventus;
Received royalties from Wolters Kluwer.

Publications
Federal Practitioner
Topics
Pain
Author and Disclosure Information

Reviewed by: 

 

Terri L. Tanielian, MA, Founder, CEO, Bluebird Road Advisors, Washington, DC
Ms. Tanielian has disclosed no relevant financial relationships.

 

Scott G. Pritzlaff, MD, Associate Professor, Department of Anesthesiology and Pain Medicine, University of California, Davis, Sacramento, California
Dr. Pritzlaff has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant,
or trustee for: SPR Therapeutics; Medtronic, and Bioventus;
Received royalties from Wolters Kluwer.

Author and Disclosure Information

Reviewed by: 

 

Terri L. Tanielian, MA, Founder, CEO, Bluebird Road Advisors, Washington, DC
Ms. Tanielian has disclosed no relevant financial relationships.

 

Scott G. Pritzlaff, MD, Associate Professor, Department of Anesthesiology and Pain Medicine, University of California, Davis, Sacramento, California
Dr. Pritzlaff has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant,
or trustee for: SPR Therapeutics; Medtronic, and Bioventus;
Received royalties from Wolters Kluwer.

Click to view more from Federal Health Care Data Trends 2025.

Click to view more from Federal Health Care Data Trends 2025.

References
  1. Baumann L, et al. Curr Pain Headache Rep. 2023;27(9):437-444. doi:10.1007/s11916-023-01127-0
  2. Reif S, et al. Mil Med. 2018;183(9-10):e330-e337. doi:10.1093/milmed/usx200
  3. Sharp LK, e t a l . Pain. 2023;164( 4 ) : 749-757. doi:10.1097/j .pain.0000000000002759
  4. Dalton MK, et al. J Trauma Acute Care Surg. 2021;91(2S Suppl 2):S213-S220. doi:10.1097/TA.0000000000003133
  5. Mahyar L, et al. Reg Anesth Pain Med. 2024;49(2):117-121. doi:10.1136/rapm-2023-104610
  6. Gupta K, et al. Eur J Trauma Emerg Surg. 2025;51(1):103. doi:10.1007/s00068-025-02778-x
  7. Mariano ER, et al. Reg Anesth Pain Med. 2022;47(2):118-127. doi:10.1136/rapm-2021-103083
References
  1. Baumann L, et al. Curr Pain Headache Rep. 2023;27(9):437-444. doi:10.1007/s11916-023-01127-0
  2. Reif S, et al. Mil Med. 2018;183(9-10):e330-e337. doi:10.1093/milmed/usx200
  3. Sharp LK, e t a l . Pain. 2023;164( 4 ) : 749-757. doi:10.1097/j .pain.0000000000002759
  4. Dalton MK, et al. J Trauma Acute Care Surg. 2021;91(2S Suppl 2):S213-S220. doi:10.1097/TA.0000000000003133
  5. Mahyar L, et al. Reg Anesth Pain Med. 2024;49(2):117-121. doi:10.1136/rapm-2023-104610
  6. Gupta K, et al. Eur J Trauma Emerg Surg. 2025;51(1):103. doi:10.1007/s00068-025-02778-x
  7. Mariano ER, et al. Reg Anesth Pain Med. 2022;47(2):118-127. doi:10.1136/rapm-2021-103083
Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
Pain
Article Type
Article
Display Headline

Data Trends 2025: Acute Pain

Display Headline

Data Trends 2025: Acute Pain

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
SLIDESHOW
Gate On Date
Tue, 07/15/2025 - 20:20
Un-Gate On Date
Tue, 07/15/2025 - 20:20
Use ProPublica
CFC Schedule Remove Status
Tue, 07/15/2025 - 20:20
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Article Slideshow Optional Introduction

Veterans experience acute pain for a multitude of reasons, ranging from combat-related injuries to routine medical procedures, such as surgeries or dental extractions.1-3 Opioid use disorder is a concern within the VA and in the acute pain setting, with one study finding that 98% of veterans with combat-related injuries from 2007-2011 were prescribed opioids.1,4 Anesthesiologist-led acute pain services play a vital role in managing acute pain among veterans, reducing the incidence of opioid-related adverse effects, and facilitating more streamlined, coordinated care pathways that support timely recovery and discharge.5,6

VA dental providers have reported concerns about opioid-prescribing decisions for clinical scenarios with acute pain present in light of the opioid epidemic.3 Guidelines released in 2022 for acute perioperative pain management emphasized acute pain services and thorough preoperative evaluation to help prevent negative opioid-related situations.7

Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date
Tue, 07/15/2025 - 20:20
Slide Media